Puberty blockers and gender-affirming hormones are rarely prescribed to U.S. transgender and gender diverse (TGD) adolescents, according to a new study from researchers at Harvard T.H. Chan School of Public Health, Harvard Pilgrim Health Care Institute, and FOLX Health.
Futura Medical and Haleon partner to commercialise Eroxon gel in US – Pharmaceutical Technology
MED3000 (marketed as Eroxon in the UK) became the first erectile dysfunction gel available to patients in the US without the need for a doctor’s
July 17, 2023